You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 12, 2024

OXYCODONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for OXYCODONE?
  • What are the global sales for OXYCODONE?
  • What is Average Wholesale Price for OXYCODONE?
Drug patent expirations by year for OXYCODONE
Drug Prices for OXYCODONE

See drug prices for OXYCODONE

Drug Sales Revenue Trends for OXYCODONE

See drug sales revenues for OXYCODONE

Recent Clinical Trials for OXYCODONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Henry Ford Health SystemPhase 4
University of MiamiPhase 3
Murdoch Childrens Research InstitutePhase 4

See all OXYCODONE clinical trials

Medical Subject Heading (MeSH) Categories for OXYCODONE
Anatomical Therapeutic Chemical (ATC) Classes for OXYCODONE
Paragraph IV (Patent) Challenges for OXYCODONE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
XTAMPZA ER Extended-release Capsules oxycodone 9 mg, 13.5 mg, 18 mg, 27 mg and 36 mg 208090 1 2017-11-15

US Patents and Regulatory Information for OXYCODONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 040550-002 Jun 30, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 040535-002 Sep 5, 2003 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurolife Pharma Llc OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 201972-003 Jul 15, 2013 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal Pharms Ny OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 040778-001 Nov 27, 2007 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.